Wczytywanie spółki
Just reported
Q4 FY2026 results
From Azenta's results release of 10 listopada 2026. These are the company's first figures; its 10-Q or 10-K replaces them when filed.
Revenue
Actual
167,1M USD
+5,0% y/y
+3,7% q/qGuided
—
No guide given
EPS, adjusted
Actual
0,28 USD
Guided
—
No guide given
Operating income, GAAP
Actual
2,5M USD
+32% y/y
Guided
—
No guide given
Operating income, adjusted: 11,5M USD
Company outlook
Full year 2027
- Revenue648M USD – 660M USDFirst given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The full earnings report →Keep exploring
The themes Azenta is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Highest-graded in Medical Instruments and Supplies
Graded A or B and worth $2B or more: A first, then the largest.
ISRGIntuitive Surgical, Inc.153,8B USDA+
MDLNMedline Inc.51,9B USDA
ALCAlcon Inc.36,1B USDA
BLCOBausch & Lomb Corp7,5B USDA-
ATRCAtriCure, Inc.2,9B USDA
Grade rose recently in Healthcare
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher Corporation21 paź 2026CBGraded C, now B
MCKMckesson Corporation4 lis 2026BAGraded B, now A
CVSCVS Health Corp4 lis 2026BAGraded B, now A
EWEdwards Lifesciences Corporation4 lis 2026BAGraded B, now A
GEHCGE Healthcare Technologies Inc.28 paź 2026CAGraded C, now A
Pełne sprawozdania finansowe →
Zbudowane z własnych raportów spółki Azenta, Inc. składanych do amerykańskiej Komisji Papierów Wartościowych i Giełd (SEC). Liczby są takie, jak zaraportowano, a historia na akcję przeliczona na dzisiejszą bazę akcji. To opisuje firmę — nie jest poradą inwestycyjną ani rekomendacją kupna lub sprzedaży.
